Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05584176 · ClinicalTrials.gov registry record · NA
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
A NA study, sponsored by MP Biomedicals.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
NCT05584176 is a NA study that has completed, run by MP Biomedicals. The registered enrollment target is 332 participants.
The verdict
NCT05584176, a NA study, has completed, sponsored by MP Biomedicals.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
Study Summary
SARS-CoV-2 rapid antigen over the counter clinical performance evaluation
Interventions
- DEVICE iCura COVID-19 Antigen Rapid Home Test
- DEVICE RT-PCR Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2022-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05584176
The ClinicalTrials.gov registry entry for NCT05584176 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MP Biomedicals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iCura COVID-19 Antigen Rapid Home Test is the first listed.
NCT05584176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05584176 about?
NCT05584176 is a clinical study titled "COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation". SARS-CoV-2 rapid antigen over the counter clinical performance evaluation
What is the current status of trial NCT05584176?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2021-12-09. Estimated completion is 2022-01-21.
What interventions are being tested in trial NCT05584176?
The interventions under investigation include: iCura COVID-19 Antigen Rapid Home Test (DEVICE), RT-PCR Test (DEVICE).
Who is sponsoring clinical trial NCT05584176?
This trial is sponsored by MP Biomedicals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.